FDA Inspection 708208 — Idaho Center for Reproductive Medicine

Idaho Center for Reproductive Medicine — FEI 3007327551

The FDA completed an inspection of Idaho Center for Reproductive Medicine on January 24, 2011 in Boise, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 24, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boise, ID (United States)

Citations

IDCFRDescription
1228821 CFR 1271.80(c)Manufacturer instructions not followed